Telmisartan 40 mg + HCTZ 12.5 mg (Tab)
Brand Name: TELVELLA-CT
Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets
Product Overview
- TELVELLA-CT is a synergistic antihypertensive formulation combining Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan selectively displaces angiotensin II from the AT1 receptor subtype, directly preventing potent vasoconstriction and aldosterone secretion. Chlorthalidone inhibits Na+/Cl- reabsorption in the distal convoluted tubule of the nephron, promoting renal excretion of sodium and water to significantly lower systemic vascular resistance, blood volume, and mean arterial pressure.
- Designed for comprehensive blood pressure control, this dual combination pairs a vessel relaxer with a fluid-clearing agent. It opens up tight, narrow blood vessels while helping the kidneys flush out extra salt and fluid, easing the overall strain on the heart and circulatory system.
- Developed under stringent quality standards, TELVELLA-CT ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Uncontrolled Essential Hypertension.
Therapeutic Benefits / Key Features
- Dual mechanism offering additive blood pressure reduction.
- Enhances cardiovascular and renal protection in hypertensive patients.
- Promotes effective fluid balance and reduces vascular resistance.
- Once-daily dosing ensures better adherence and sustained efficacy.
Brand Composition
Each film-coated tablet contains:
- Telmisartan I.P. 40 mg
- Hydrochlorothiazide I.P. 12.5 mg
Why this formulation matters
- Provides enhanced efficacy over monotherapy in moderate-to-severe hypertension.
- Reduces the need for dose escalation and lowers overall pill burden.
- Demonstrated superior blood pressure normalization throughout the 24-hour cycle.
- Ideal for patients with inadequate response to single-agent therapy.
Division Identity
Part of Yaselle Cardiora – Cardiac & Hypertension Care Division
Protecting every heartbeat with science and care